“I hope there will be 5-6 million doses of vaccine by November, which will be produced at 4-5 sites.
This will allow to vaccinate the population within 9-12 months, to reach the level of vaccination of 70-80%, which will allow to stop the circulation of this pathogen at the population level, ”Interfax quotes him as saying at a press conference.
Gunzburg noted that 14-15% of volunteers who received the first component of the COVID-19 vaccine experienced side effects.
Thus, 85% of volunteers do not experience complications after vaccination, the director emphasized.
Earlier, Gunzburg said that trial batches of the Sputnik V COVID-19 vaccine had arrived in all Russian regions.